Press Releases
genOway offers industry scientists immediate access to EUCOMM conditional KO mouse models
genOway guarantees freedom to operate (FTO) and offers important gains in conditional knockout development time for industry scientists
Lyon, France, July 2, 2014 - genOway (Alternext-NYSE Euronext: ALGEN; ISIN: FR0004053510), the biotechnology company dedicated to the development of genetically modified...
Press Releases
Cancer research departments need to think beyond checkpoint inhibitors
Cancer immunotherapy research departments need to break their obsession with the latest flavour of the month - checkpoint inhibitors - and concentrate more on combining checkpoint inhibitors with APC activators, thinks Dr. Frederic Triebel, the founder of the French...
Press Releases
Provepharm and Dr Franz Kohler Chemie partner to provide Methylthioninium chloride Proveblue solution for injection to Germany
Proveblue(R) is the methylthioninium chloride or Methylene Blue active substance patented by Provepharm, compliant with current European Pharmacopeia standards Provepharm, a French company specialized in the development of pharmaceutical applications, and Dr Franz Kohler Chemie (DFKC),...
Press Releases
Ferrer initiates second phase III clinical study for Ozenoxacin in adult and paediatric patients with impetigo
Ozenoxacin, a novel bactericidal non-fluorinated quinolone that successfully completed a first phase III clinical trial in adult and paediatric patients with impetigo, is available from Ferrer for licensing and commercialisation Ferrer, a privately-held Spanish pharmaceutical company,...
Press Releases
State-owned British research institute fund Clinical trial of Airsonett – an innovative Swedish asthma treatment
There are 5 million persons suffering from asthma in Great Britain and despite medication, half a million of these persons have symptoms which limit their daily life. In some serious cases, the asthma develop may into a life-threatening condition....
Press Releases
Point of Care Set to Boom in Coming Years; Driving Forward Quality and Maximising Efficiency
The global market for Point of Care diagnostics is set to sharply increase by 2018 and Europe’s market is becoming increasingly competitive due to its low barriers of entry. Based on this information SMi is proud...
Press Releases
The Orphan Drugs Market is set to Rise as a Result of Pharma Companies now Looking to Orphan Drugs as an Essential...
As of January 2014, the EMA lifted the restriction on providing fee reductions to large companies developing new orphan drugs and the Early Access to Medicines Scheme was introduced. Key implementation of this will be a factor into further...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read